An interventional study of Vaginal Ultrasonography and Magnetic Resonance Imaging in Placenta Previa, sponsored by Ege University. Completed at 1 site in Turkey. Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-03-23.
Sponsored by Ege University · Not applicable, Interventional, and Diagnostic
Placenta previa cases are one of the difficult groups of patients to manage in modern obstetrics. When the literature is evaluated extensively, no clear information can be seen especially in terms of hospitalization time. Inpatient follow-up of this patients has negative effects like hospital infections in terms of the patient, workload in terms of health personnel and financial losses in terms of the country's economy. Placenta previa cases are complicated patients in which generalizations cannot be easily performed and they should be monitored at third level hospitals. In addition, care should be personalized considering the many reasons. In this study, placenta previa cases will be followed up at 28th gestational week and evaluated at 32nd week by vaginal ultrasonography and MRI and this follow-up will continue until delivery. Thus, in this study, it was aimed to determine the parameters that would allow systematic personalization of health service in this particular patient group by making risk assessment of placenta previa cases.
80 studies on the registry are indexed under Placenta Previa; 17 are open to participants now.
This study's enrollment of 98 is below the median of 109 across 45 interventional studies indexed under Placenta Previa.
Browse Placenta Previa studies →Ege University is the lead sponsor of 377 studies on the registry; 48 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Placenta previa cases will be evaluated at 32nd week by vaginal ultrasonography and MRI.
Diagnostic Test: Vaginal Ultrasonography · Diagnostic Test: Magnetic Resonance Imaging
Placenta previa cases will be evaluated at 32nd week by vaginal ultrasonography for invasion anomaly and preterm birth.
Placenta previa cases will be evaluated at 32nd week by MRI for invasion anomaly and preterm birth.
The number of placental invasion pathologies
Placental invasion pathologies detected during delivery will be evaluated.
Time frame: 1 day
The number of preterm birth
The relation between preterm birth and placental invasion pathologies will be assessed.
Time frame: 1 day
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.